guideSEQ: Genomic Understanding, Impact, Decision & Ethics in Prenatal Sequencing
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Columbia University
- Study ID
- NCT07610590
- Status
- Recruiting
Conditions
- Prenatal Genetic Diagnosis
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Genome Sequencing (GS) — GENETICGenome sequencing (GS) is a genetic test that involves reading the genome to identify genetic changes (also known as "genetic variants") that can cause differences in human development and disease.
Study Details
This study looks at whether genome sequencing should be used more routinely during pregnancy, even when ultrasounds look normal. Genome sequencing can examine nearly all of a baby's genes and may find genetic conditions that standard tests do not detect. Researchers will compare this test with current prenatal testing to see if it provides helpful information for families and doctors. The study will also explore how parents decide what kinds of genetic information they want to receive and how this information affects their experience during pregnancy. The goal is to understand whether genome sequencing can be used in a way that is helpful, responsible, and supportive for families in the future.
Key Dates
- Start date
- Apr 29, 2026
- Status verified
- May 2026
- Primary completion
- Jul 31, 2029
- Completion
- Jul 31, 2029
Study Design
- Enrollment
- 1,042 participants (estimated)
Primary Outcome Measure
Incremental Genomic Frequency [ Time Frame: Baseline to 12 months postpartum. ]
Central Contacts
- Camila Zarate, MPH646-300-0197
- Jessica Giordano, MS, CGC516-521-5604
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Boston Childrens Hospital | Boston | Massachusetts | 02115 | - |
| Columbia University Irving Medical Center (CUIMC) | New York | New York | 10032 | Ronald Wapner, MD (PRINCIPAL_INVESTIGATOR) |
| New York Genome Center | New York | New York | 10013 | - |